EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A non-local diffusion magnetic resonance imaging tract density biomarker to stratify, predict, and interpret survival rates in human glioblastoma

Joan Falcó-Roget iD, Gianpaolo Antonio Basile iD, Anna Janus iD, Sara Lillo iD, Letterio S Politi iD, Jan K Argasinski iD, Alberto Cacciola iD

Neuro-Oncology · 2026

DOI: 10.1093/neuonc/noaf234 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, 2026. Verfasst von Joan Falcó-Roget und 6 weiteren Autor:innen. Beteiligte Einrichtung: Computational Neuroscience Group, Sano Centre for Computational Medicine, Kraków, Poland (J.F.-R., A.J., J.K.A.). Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Diffusion Magnetic Resonance Imaging, White Matter. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Science Centre, European Union's Horizon 2020 research and innovation programme, International Research Agendas Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glioblastoma (GBM) is a lethal tumor, actively growing and invading neighboring neural tissue. GBMs appear functionally connected to distributed and spatially distant regions rather than representing an isolated and passive lesion disrupting the brain circuitry. Moreover, increasing evidence suggests that white matter serves as the morphological substrate for GBM to progress and migrate to distant areas in the human brain.

Methods

We hypothesized that the subset of white matter tracts intersecting the tumors depicts the physical substrate for large-scale neuron-glioma interactions and would therefore inform prognosis. Using normative models, we design, analyze, interpret, and test a Lesion-Tract Density Index (L -TDI) marker that considers the distributed white matter pathways interacting with the tumor in 2 independent cohorts of N=367 and N=496 patients, respectively.

Results

First, we show that the tract density within this white matter map robustly stratifies survival rates due to widespread white matter involvement. Second, we demonstrate why tract density-based markers offer critical and necessary insights into the morphology, location, and evolution of human GBM by proving how the proposed L -TDI implicitly considers tumor volume, white matter density, and location. We provide further evidence that the non-uniform distribution of GBMs and their differential prognosis emerge from white matter morphology. Third, we validate the L -TDI marker with multiple Cox survival models and analyze its contribution in relation to other covariates of interest (eg, MGMT promoter methylation). Lastly, by using a simple logistic model, we predict patient death at 12 months with balanced accuracies of 68% and 65%, and areas under the curve of 0.74 and 0.73 when training and testing in separate and independent cohorts.

Conclusions

Overall, we offer a concrete implementation of the emerging paradigm that views GBM not as a focal lesion, but as a network disease sh aped by its complex interactions with distant brain regions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsDiffusion Magnetic Resonance ImagingWhite MatterHumansPrognosisMaleFemaleSurvival RateMiddle AgedBiomarkers, TumorAdultAgedFollow-Up StudiesDNA Repair EnzymesTumor Suppressor ProteinsDNA Modification Methylases

Stichwörter der Autor:innen

brain connectomediffusion tractographyglioblastomasurvival prediction

Substanzen

Biomarkers, TumorMGMT protein, humanDNA Repair EnzymesTumor Suppressor ProteinsDNA Modification Methylases

Autor:innen und Institutionen

  • Computational Neuroscience Group, Sano Centre for Computational Medicine, Kraków, Poland (J.F.-R., A.J., J.K.A.).
  • Brain Mapping Lab, Department of Biomedical, Dental Sciences and Morphological and Functional Imaging, University of Messina, Messina, Italy (G.A.B.).
  • Department of Neurophysiology and Chronobiology, Institute of Zoology and Biomedical Research, Faculty of Biology, Jagiellonian University, Krakow, Poland (A.J.).
  • Radiation Oncology Unit, Clinical Department, CNAO National Center for Oncological Hadrontherapy, Pavia, Italy (S.L.).
  • Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy (S.L.).
  • Department of Biomedical Sciences, Humanitas University, , Milan, Italy (L.S.P., A.C.).

ORCID-Profile: Joan Falcó-Roget, Gianpaolo Antonio Basile, Anna Janus, Sara Lillo, Letterio S Politi, Jan K Argasinski, Alberto Cacciola

Förderung

  • National Science Centre
  • European Union's Horizon 2020 research and innovation programme
  • International Research Agendas Programme
  • Foundation for Polish Science
  • Minister of Science and Higher Education "Support
  • Centers of Excellence established in Poland
  • National Plan for NRRP Complementary Investments
  • European Union’s Horizon 2020 research and innovation programme

Zitieren

APA

Falcó-Roget, J., Basile, G. A., Janus, A., Lillo, S., Politi, L. S., Argasinski, J. K., & Cacciola, A. (2026). A non-local diffusion magnetic resonance imaging tract density biomarker to stratify, predict, and interpret survival rates in human glioblastoma. Neuro-Oncology. https://doi.org/10.1093/neuonc/noaf234

Vancouver

Falcó-Roget J, Basile GA, Janus A, Lillo S, Politi LS, Argasinski JK, et al. A non-local diffusion magnetic resonance imaging tract density biomarker to stratify, predict, and interpret survival rates in human glioblastoma. Neuro-Oncology. 2026. doi:10.1093/neuonc/noaf234

BibTeX
@article{FalcRoget2026,
  author = {Falcó-Roget, Joan and Basile, Gianpaolo Antonio and Janus, Anna and Lillo, Sara and Politi, Letterio S and Argasinski, Jan K and Cacciola, Alberto},
  title = {A non-local diffusion magnetic resonance imaging tract density biomarker to stratify, predict, and interpret survival rates in human glioblastoma},
  journal = {Neuro-Oncology},
  year = {2026},
  doi = {10.1093/neuonc/noaf234}
}
Kostenlos starten →